ArticleInvestigational new drugs2024

Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).

Kazufumi Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.